Active Ingredient: CERITINIB
Proprietary Name: ZYKADIA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N211225
Product Number: 001
Approval Date: Mar 18, 2019
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
